Welcome members and clients of OMMP PIF. Due to increased costs, our website has moved to this server, Thanks go to our Friend and colleague, Wired57, for making this possible. If you have any questions or concerns, please start a new topic in 
Thank you 
04-16-2012, 10:49 PM
Terminally Ill
Should marijuana be a medical option for patients with a terminal illness and suffering severe pain?
The Institute of Medicine published in its Mar. 1999 report titled "Marijuana and Medicine: Assessing the Science Base": "Terminal cancer patients pose different issues. For those patients the medical harm associated with smoking is of little consequence. For terminal patients suffering debilitating pain or nausea and for whom all indicated medications have failed to provide relief, the medical benefits of smoked marijuana might outweigh the harm."
Consumer Reports, a nonprofit magazine, stated in May 1997: "Consumer Reports believes that, for patients with advanced AIDS and terminal cancer, the apparent benefits some derive from smoking marijuana outweigh any substantiated or even suspected risks. In the same spirit the FDA uses to hasten the approval of cancer drugs, federal laws should be relaxed in favor of states' rights to allow physicians to administer marijuana to their patients on a caring and compassionate basis."
More
PDF
Trials of cannabis pain relief raise hope for terminally ill
Cannabis could be used to help relieve the pain suffered by desperately ill cancer patients following successful trials by GW Pharmaceuticals.
The company, which was set up to create drugs derived from cannabis plants grown at secret locations in Britain, said yesterday that the results of the trials had been "statistically significant".
Patients in the study had advanced cancer and were suffering pain that had not been responding to the usual medication such as morphine.
The company said the trial found that approximately 40% of the patients given its Sativex oral spray showed a greater than 30% improvement in the relief of their pain.
Sativex, a cannabis medicine containing tetrahydrocannabinol and cannabidiol, has not yet received regulatory approval in the UK, despite GW Pharma's initial hopes that it would be given the green light at the end of 2003.
My link
The group's loss for the year to end-September widened to 13.1m from 8.1m in 2003, when the company received a 5m signature fee from Bayer.
Its shares rose 3p to 120.5p. They traded at over 165p before the news in early December that the UK authorities were demanding another trial.
Should marijuana be a medical option for patients with a terminal illness and suffering severe pain?
The Institute of Medicine published in its Mar. 1999 report titled "Marijuana and Medicine: Assessing the Science Base": "Terminal cancer patients pose different issues. For those patients the medical harm associated with smoking is of little consequence. For terminal patients suffering debilitating pain or nausea and for whom all indicated medications have failed to provide relief, the medical benefits of smoked marijuana might outweigh the harm."
Consumer Reports, a nonprofit magazine, stated in May 1997: "Consumer Reports believes that, for patients with advanced AIDS and terminal cancer, the apparent benefits some derive from smoking marijuana outweigh any substantiated or even suspected risks. In the same spirit the FDA uses to hasten the approval of cancer drugs, federal laws should be relaxed in favor of states' rights to allow physicians to administer marijuana to their patients on a caring and compassionate basis."
More
Trials of cannabis pain relief raise hope for terminally ill
- Jill Treanor
- The Guardian, Wednesday 19 January 2005 21.17 EST
- Article history
Cannabis could be used to help relieve the pain suffered by desperately ill cancer patients following successful trials by GW Pharmaceuticals.
The company, which was set up to create drugs derived from cannabis plants grown at secret locations in Britain, said yesterday that the results of the trials had been "statistically significant".
Patients in the study had advanced cancer and were suffering pain that had not been responding to the usual medication such as morphine.
The company said the trial found that approximately 40% of the patients given its Sativex oral spray showed a greater than 30% improvement in the relief of their pain.
Sativex, a cannabis medicine containing tetrahydrocannabinol and cannabidiol, has not yet received regulatory approval in the UK, despite GW Pharma's initial hopes that it would be given the green light at the end of 2003.
My link
The group's loss for the year to end-September widened to 13.1m from 8.1m in 2003, when the company received a 5m signature fee from Bayer.
Its shares rose 3p to 120.5p. They traded at over 165p before the news in early December that the UK authorities were demanding another trial.